Skip to main content
Biology LibreTexts

12.1C: Development of New Vaccines

  • Page ID
    11820
  • \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    New vaccines are being developed to control recent infectious disease epidemics and cancers.

    Learning Objectives
    • Describe how new vaccines are being developed to help eradicate several infectious global diseases

    Key Points

    • The World Health Organization (WHO) oversees the development and distribution of vaccines for underdeveloped countries.
    • Vaccines for rotavirus diarrhea, pneumococcal disease, and meningococcal infections have been licensed and are approved for development.
    • Vaccines for cancer treatment are gaining traction and are based on training the body to recognize cancer cells as foreign.

    Key Terms

    • vaccine: a substance given to stimulate the body’s production of antibodies and provide immunity against a disease, prepared from the agent that causes the disease, or a synthetic substitute.
    • immunization: the process by which an individual is exposed to a material that is designed to prime his or her immune system against that material.

    National Immunization Programs

    The implementation of large-scale, comprehensive national immunization programs, and the considerable successes that were achieved in the eradication of smallpox and the reduction of polio, measles, pertussis, tetanus, and meningitis, were among the most notable achievements of the 20th century. Even in the poorest countries, immunizations have been able to achieve significant progress in disease control. There is good reason to expect that these advances will be sustained and will progress even further in the 21stcentury.

    Vaccines for Infectious Diseases

    image
    Figure: Human papillomavirus vaccine: Gardasil is a human papillomavirus vaccine on the market and it protects against HPV-16 and HPV-18 which cause 70% of cervical cancers, 80% of anal cancers, 60% of vaginal cancers, and 40% of vulvar cancers.

    A number of new vaccines with major potential for controlling infectious diseases have just been licensed or are at advanced stages of development. Among the illnesses targeted are rotavirus diarrhea, pneumococcal disease, and cervical cancer (as caused by human papillomavirus), which together kill more than a million people each year, most of them in developing countries.

    In addition to these efforts against global diseases, progress is being made on a vaccine for the regional menace posed by meningococcal meningitis serogroup A, which causes frequent epidemics and high death rates and disability in African countries south of the Sahara. Continuing intensive efforts are under way to develop effective vaccines for AIDS, malaria, tuberculosis, dengue, leishmaniasis, and enteric diseases, among others and to adapt new technologies to improve formulation and delivery. The World Health Organization (WHO) facilitates the development of vaccines against infectious diseases of major public health importance, helps improve existing immunization technologies, and ensures that these advances are made available to the people who need them the most.


    12.1C: Development of New Vaccines is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by LibreTexts.

    • Was this article helpful?